Monday, May 4, 2015
- 5:00pm-5:12pm
-
Alemtuzumab Induction Has Been Safe in the United Kingdom and Achieves Long-Term Steroid Avoidance in More Than 80% of Low Risk Renal Transplant Recipients
Concurrent Session: Kidney: Induction • Room 120-ABC
- 5:00pm-5:12pm
-
Clinical and Pathologic Predictors of Response to Belatacept Conversion
Concurrent Session: Kidney: Novel Agents • Terrace I-III
- 5:00pm-5:12pm
-
Effect of Patient Functional Status on the Associations Between Kidney Transplant Waitlisting, Race, and U.S. Region
Concurrent Session: Disparities in Healthcare Access • Room 115-C
- 5:00pm-5:12pm
-
In Vitro Evidence That CTLA4Ig Attenuates Recall Alloantibody Responses
Concurrent Session: T Cell Help and Alloimmunity • Room 118-C
- 5:00pm-5:12pm
-
Kidney Transplantation Using Kidneys from Donation After Circulatory Death Donors: Results from the UK Experience
Concurrent Session: Kidney: KDPI and Non Ideal Kidneys • Room 118-AB
- «Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 48
- Next Page»